Virtus ETF Advisers’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,788
| Closed | -$59.8K | – | 633 |
|
|
2024
Q4 | $59.8K | Sell |
10,788
-762
| -7% | -$4.22K | 0.02% | 450 |
|
|
2024
Q3 | $96.3K | Buy |
11,550
+206
| +2% | +$1.72K | 0.05% | 381 |
|
|
2024
Q2 | $77.3K | Sell |
11,344
-2,028
| -15% | -$13.8K | 0.04% | 419 |
|
|
2024
Q1 | $87.7K | Sell |
13,372
-915
| -6% | -$6K | 0.05% | 383 |
|
|
2023
Q4 | $92.7K | Buy |
14,287
+5,883
| +70% | +$38.2K | 0.06% | 394 |
|
|
2023
Q3 | $42.3K | Sell |
8,404
-835
| -9% | -$4.2K | 0.03% | 419 |
|
|
2023
Q2 | $80.8K | Buy |
+9,239
| New | +$80.8K | 0.05% | 428 |
|